Nexviazyme (avalglucosidase alfangpt)
Billing
Code: J0219
Description: Inj aval alfa-nqpt 4mg
Unit: 4 mg
Payment: $72.506
Pay quarter: Q1 2023
Dosage and Frequency
Pompe disease
• 20mg/kg IV every 2 weeks if patient weighs 30kg or more
• 40mg/kg IV every 2 weeks if patient weighs less than 30kg
• 20mg/kg IV every 2 weeks if patient weighs 30kg or more
• 40mg/kg IV every 2 weeks if patient weighs less than 30kg
Calculate drug reimbursement
Total Reimbursement:
$30,742.54(ASP: $29,002.40, Margin: $1,740.14)
Code:
J0219# Units to bill:
400Prior Authorization
Prior auth criteria for Nexviazyme may include but is not limited to:
Insurance prior auth guidelines:
Billable NDCs
58468-0426-01
Nexviazyme (GENZYME CORPORATION)
100 mg
Resources